Optima Health plc
Director / PDMR Dealing
Optima Health plc (Company) announces that on 23 September 2026, awards were granted under the Optima Health plc Performance Share Plan (PSP) to certain directors and PDMRs.
The Awards take the form of nil-cost options which vest on the second anniversary of grant, subject to certain conditions including continued employment with the group and the achievement of performance targets. 50% of the shares that vest are then subject to a further one year holding period before they can be exercised.
In addition, further to the information on the 2024 Share Plan set out in the Company’s Admission Document and the recent notice of Annual General Meeting, the Company confirms that awards under the 2024 share plan have been granted to a number of senior management/PDMRs. Subject to achievement of the performance hurdle, nil cost options would be granted to the relevant participants according to the plan rules.
The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation as incorporated into the law of England and Wales, and set out more details of the transactions.
|
1. |
Details of PDMR |
|||||
|
(a) |
Name |
1. Jonathan Thomas 2. Andy Bones 3. Joanne Newey |
||||
|
2. |
Reason for notification |
|||||
|
(b) |
Position / status |
1. Chief Executive Officer 2. Chief Financial Officer 3. Chief Commercial Officer (PDMR) |
||||
|
(c) |
Initial notification / amendment |
Initial notification |
||||
|
3. |
Details of the Issuer |
|||||
|
(a) |
Name |
Optima Health plc |
||||
|
(b) |
LEI |
213800TOPWJSRCW4ON08 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted |
|||||
|
(a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares in the capital of Optima Health plc (Shares) GB00BRSCY602 |
||||
|
(b) |
Nature of the transaction |
Grant of an option under the PSP to acquire Shares at nil cost |
||||
|
(c) |
Price(s) and volume |
|
||||
|
(d) |
Aggregated information |
|
||||
|
(e) |
Date of the transaction |
23 September 2026 |
||||
|
(f) |
Place of the transaction |
Outside a trading venue |
||||
|
Name of PDMR |
Cumulative % of total value of 2024 Share Plan value (subject to performance hurdles) |
|
Jonathan Thomas |
50% |
|
Joanne Newey |
10% |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.